Comparison of immune reactivity and pharmacokinetics of two hepatitis B immune globulins in patients after liver transplantation

Hepatology

Volumn 29, Issue 4, 1999, Pages 1299-1305

  Adler, Ruth ^a   Safadi, Rifaat ^a   Caraco, Yoseph ^a   Rowe, Mina ^a   Eizioni, Amos ^b   Ashur, Yaffa ^a   Shouval, Daniel ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE; OMRI HEP B; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GRAFT INFECTION; HEPATITIS B; HUMAN; IMMUNOREACTIVITY; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; LIVER PROTECTION; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0032923308     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290446     Document Type: Article

References (18)

1. Müller R, Gubernatis G, Farle M, Niehoff G, Klein H, Wittekind C, Tusch G, et al. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 1991;13:90-96.
2. Gugenheim J, Crafa F, Fabiani P, Militerno G, Goubaux B, Saint-Paul MC, Ouzan D, et al. Recurrence of virus B hepatitis after liver transplantation. Gastroenterol Clin Biol 1992;16:430-433.
3. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou JP, Bismuth H. Liver transplant in European patients with the hepatitis B surface antigen. N Engl J Med 1993;329:1842-1847.
4. Perrillo RP, Mason AL. Hepatitis B and liver transplantation. Problems and promises. N Engl J Med 1993;329:1885-1887.
5. Kiyasu PK, Ishitani MB, McGory RW, Gaffey MJ, Dickson RC, Caldwell SH, Stevenson WS, et al. Prevention of hepatitis B "rerecurrence" after a second liver transplantation - the role of maintenance of polyclonal HBIG therapy. Transplantation 1994;58:954-956.
6. Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, Ascher NL, Wright TL. Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin. HEPATOLOGY 1996;24:1327-1333.
7. al-Hemsi B, McGory RW, Shepard B, Ishitani MB, Stevenson WC, McCullough CS, Pruett TL. Liver transplantation for hepatitis B cirrhosis: clinical sequela of passive immunization. Clin Transplant 1996;10: 668-675.
8. Ishitani M, McGory R, Dickson R, Caldwell S, Bickston S, McCullough C, Pruett T, et al. Retransplantation of patients with severe posttransplant hepatitis B in the first allograft. Transplantation 1997;64:410-414.
9. Gugenheim J, Baldini E, Ouzan D, Mouiel J. Absence of initial viral replication and long term high dose immunoglobulin administration improve results of hepatitis B virus recurrence prophylaxis after liver transplantation. Transplant Proc 1997;29:517-518.
10. Burbach GJ, Bienzle U, Neuhaus R, Hopf U, Metzger WG, Pratscke J, Neuhaus P. Intravenous or intramuscular anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation. Transplantation 1997;63:478-480.
11. Stephan W. Inactivation of hepatitis viruses and HIV in plasma derivatives by treatment with β-propiolactone/UV irradiation. Curr Stud Hematol Blood Transfus 1989;56:122-127.
12. Stephan W, Fasold. Intravenöses human-immunbglobulin durch chemische modifizierung mit β-propiolacton. Radiochemische unterschungen. Arzneim-Forsch 1980;30:2090-2093.
13. Tur-Kaspa R, Klein A, Aharonson S. Hepatitis B virus precore mutants are identical in carriers from various ethnic origins and are associated with a range of liver disease severity. HEPATOLOGY 1992;16:1338-1342.
14. Chao Y-C, Lee C-M, Tang H-S, Govindarajan S, Lai MMC. Molecular cloning and characterization of an isolate of hepatitis delta virus from Taiwan. HEPATOLOGY 1991;13:345-352.
15. Safadi R, E'id A, Ilan Y, Ashur Y, Jurim O, Shouval D. Should hepatitis B immunoglobulin therapy be discontinued after HBV reinfection following transplantation? Transplant Proc 1997;29:2680-2683.
16. Glockner WM. Kinetik von immunglobulin G nach intravenöser oder intramuskulärer applikation. In: Patient-Infektion-Immunglobulin. Munchen: Springer-Verlag 1984;33-38.
17. McGory RW, Ishitani MB, Oliveira WM, Stevenson WC, McCullough CS, Dickson RC, Caldwell SH, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996;61:1358-1364.
18. Yoffe B, Bums DK, Bhatt HS, Combes B. Extrahepatic hepatitis B virus DNA sequences in patients with acute hepatitis B infection. HEPATOLOGY 1990;12:187-192.